ReviewJournal of nutrition and metabolism2026
Implementation of Preoperative Very Low-Calorie Diets in Preparation for Metabolic and Bariatric Surgery.
Review in Journal of nutrition and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementation of Preoperative Very Low-Calorie Diets in Preparation for Metabolic and Bariatric Surgery.Journal of nutrition and metabolism · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Very low-calorie diets (VLCDs) have been commonly implemented prior to metabolic and bariatric surgery (MBS) with the goal of shrinking left liver lobe size and reducing intra-abdominal mesenteric fat. Through this manuscript, we aimed to review the available literature discussing the types of VLCDs, their mode of implementation, preoperative duration, and the intraoperative and postoperative measures. A total of 103 articles was used in the generation of this review, including 3402 MBS candidates across the studies. VLCD was shown to induce significant preoperative weight loss, reduction in body fat mass, glycemic improvement, and decrease in proinflammatory makers. Liver volume reduction of 5%-23% and abdominal wall circumference reduction of 2.0-8.5 cm were noted following short regimens of VLCD, leading to improvement in perceived intraoperative difficulty. Postoperatively, metabolic improvements and reduction in perioperative complication rates were observed in some studies. In conclusion, VLCD demonstrated potential preoperative, intraoperative, and postoperative improvements in patients undergoing MBS.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.